Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Helgeland

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|January 21, 2018
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based StudyØystein Fluge, Bård Mannsåker, Anders Torp, et al.
Microcirculation (New York, N.Y. : 1994)|January 26, 2023
Isolation of lymph shows dysregulation of STAT3 and CREB pathways in the spleen and liver during leukemia development in a rat modelEli Sihn Samdal Steinskog, Kenneth Finne, Marianne Enger, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2015
EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital TrustJanna Berg, Lars Fjellbirkeland, Pål Suhrke, et al.
Journal of Neuroimmunology|July 6, 2006
The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravisMathula Thangarajh, Thomas Masterman, Lars Helgeland, et al.
Biomedicines|October 27, 2022
Tumor HPV Status, Level of Regulatory T Cells and Macrophage Infiltration Predict up to 20-Year Non-Disease-Specific Survival in Oropharynx Squamous Cell Carcinoma PatientsHilde Haave, Borghild Ljokjel, Helene Lybak, et al.
The Biochemical Journal|March 12, 2003
The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-MybVilborg Matre, Per I Høvring, Ase-Karine Fjeldheim, et al.
Inflammatory Bowel Diseases|July 27, 2005
Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitisKari Erichsen, Anne Marita Milde, Gülen Arslan, et al.
International Journal of Cancer|August 26, 2011
Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistryOle Didrik Laerum, Kjell Ovrebo, Arne Skarstein, et al.
Haematologica|August 28, 2025
CXCR2 deficiency with myelokathexis caused by a novel variant: correction via CRISPR/Cas9Daniëla M Hinke, Sofie R Dorset, Eirik Bratland, et al.
Blood|June 20, 2023
Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cellsPascal Gelebart, May Eriksen Gjerstad, Susanne Benjaminsen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|January 21, 2018
Consolidative Radiotherapy to Residual Masses After Chemotherapy Is Associated With Improved Outcome in Diffuse Large B-Cell Lymphoma. A Retrospective, Population-Based StudyØystein Fluge, Bård Mannsåker, Anders Torp, et al.
Microcirculation (New York, N.Y. : 1994)|January 26, 2023
Isolation of lymph shows dysregulation of STAT3 and CREB pathways in the spleen and liver during leukemia development in a rat modelEli Sihn Samdal Steinskog, Kenneth Finne, Marianne Enger, et al.
Acta Oncologica (Stockholm, Sweden)|August 28, 2015
EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital TrustJanna Berg, Lars Fjellbirkeland, Pål Suhrke, et al.
Journal of Neuroimmunology|July 6, 2006
The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravisMathula Thangarajh, Thomas Masterman, Lars Helgeland, et al.
Biomedicines|October 27, 2022
Tumor HPV Status, Level of Regulatory T Cells and Macrophage Infiltration Predict up to 20-Year Non-Disease-Specific Survival in Oropharynx Squamous Cell Carcinoma PatientsHilde Haave, Borghild Ljokjel, Helene Lybak, et al.
The Biochemical Journal|March 12, 2003
The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-MybVilborg Matre, Per I Høvring, Ase-Karine Fjeldheim, et al.
Inflammatory Bowel Diseases|July 27, 2005
Low-dose oral ferrous fumarate aggravated intestinal inflammation in rats with DSS-induced colitisKari Erichsen, Anne Marita Milde, Gülen Arslan, et al.
International Journal of Cancer|August 26, 2011
Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistryOle Didrik Laerum, Kjell Ovrebo, Arne Skarstein, et al.
Haematologica|August 28, 2025
CXCR2 deficiency with myelokathexis caused by a novel variant: correction via CRISPR/Cas9Daniëla M Hinke, Sofie R Dorset, Eirik Bratland, et al.
Blood|June 20, 2023
Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cellsPascal Gelebart, May Eriksen Gjerstad, Susanne Benjaminsen, et al.
Pageof 5